Ignite Creation Date:
2025-12-24 @ 11:47 AM
Ignite Modification Date:
2026-03-26 @ 12:09 AM
Study NCT ID:
NCT02635061
Status:
TERMINATED
Last Update Posted:
2024-05-07
First Post:
2015-12-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Selective HDAC6 Inhibitor ACY 241 in Combination With Nivolumab in Patients With Unresectable Non Small Cell Lung Cancer
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-08-25
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-22
Completion Date Type:
ACTUAL
First Submit Date:
2015-12-14
First Submit QC Date:
None
Study First Post Date:
2015-12-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-06
Last Update Post Date:
2024-05-07
Last Update Post Date Type:
ACTUAL